For many readers, Retatrutide vs Semaglutide becomes a timing question
Understanding Its Role in Weight Loss Semaglutide is a GLP-1 receptor agonist, a class of medications initially designed to help manage diabetes
Semaglutide at the highest maintenance dose (2.4 mg weekly) achieved approximately 15% body weight reduction in STEP clinical trials, compared to about 10% at lower doses
Gastrointestinal Issues Nausea Vomiting Constipation Abdominal discomfort Up to 50% of patients experience GI distress, especially at the start
Adiponectin also decreases hepatic de novo glucose production and reduces free fatty acid levels in the liver (196), thereby mitigating hepatic steatosis, enhancing insulin sensitivity, and improving the circulating lipid profile ( Figure 1 Section E)
Thus, maintaining iron homeostasis is crucial for preventing oxidative damage and ensuring cellular survival